Stay updated on Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.

Latest updates to the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1. The page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details. Access to the record is blocked.SummaryDifference18%

- Check45 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a recent update to the study page's content or layout. This reflects a minor change to the page's metadata.SummaryDifference0.1%

- Check52 days agoChange DetectedA new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers. This addition links the trial to NIH funding and related grant information.SummaryDifference0.1%

- Check59 days agoChange DetectedIntroduces a Publications section with a cited PRINCEPS results article and a note that publications are provided voluntarily. Updates location entries to standardize the Val de Marne and Villejuif listings with new date markers.SummaryDifference0.7%

- Check67 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the study page, signaling a minor update to the ClinicalTrials.gov record. This reflects maintenance of the page rather than substantive changes to study data.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.